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Edited by Amy McGoughAbstract The purpose of the present study was to investigate
whether 5-hydroxytryptamine (5-HT, serotonin) aﬀects migra-
tion of vascular endothelial cells. 5-HT signiﬁcantly enhanced
migration of human aortic endothelial cells (HAECs), and this
enhancement was completely inhibited by GR 55562, a 5-HT1
receptor antagonist, and ﬂuoxetine, a 5-HT transporter inhibi-
tor, but was not aﬀected by ketanserin, a 5-HT2 receptor antag-
onist. 5-HT stimulation increased RhoA and ERK activity of
HAECs, and inhibitors of RhoA (Y-27632 and H-1152) and
inhibitors of MEK (U0126 and PD98059) abolished the 5-HT-
induced increase in migration velocity. Inhibition of Rho kinase
by Y-27632 blocked stress ﬁber formation and rear release of
HAECs. Thus, 5-HT has a potent enhancing action on migration
of HAECs through activating the RhoA and ERK pathways fol-
lowing 5-HT1 receptor stimulation.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Migration of vascular endothelial cells is involved in angio-
genesis [1], which is essential for wound repair and tumor
growth and metastasis [2]. Humoral factors such as growth
factors are known to regulate migration of vascular endothe-
lial cells [3]. 5-Hydroxytryptamine (5-HT, serotonin) is re-
leased from aggregated platelets, and platelet activation is
involved in angiogenesis [4,5]. However, there have been no
studies on 5-HT action on migration of vascular endothelial
cells except for one study that showed that 5-HT inhibited
movement of bovine aortic endothelial cells as evaluated by
cell phagokinesis [6]. On the other hand, 5-HT has been re-
ported to potentiate proliferation of vascular endothelial cells
[7,8], although the mechanism involved in this 5-HT action re-
mains to be determined. The purpose of the present study was
to investigate whether 5-HT aﬀects movement of human vas-
cular endothelial cells (HAECs) by using time-lapse micros-
copy, a sensitive method to evaluate cell motility. We also
investigated the eﬀects of 5-HT on cellular signaling that is in-
volved in vascular endothelial cell migration. We found that 5-
HT greatly augments migration of HAECs through activation
of RhoA and ERK-dependent pathways.*Corresponding author. Fax: +81 23 628 5255.
E-mail address: wakabaya@med.id.yamagata-u.ac.jp
(I. Wakabayashi).
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2.1. Cell culture
Human aortic endothelial cells (HAECs) (KURABO, Osaka, Japan)
were cultured in HuMedia-EG2 medium (KURABO) in CO2 (5%)-
containing humidiﬁed air at 37 C. The passage number of the cells
used was between 5 and 9, and conﬂuent cells were spread and cultured
in a new dish every 3–4 days.
2.2. Cell migration assay
HAECs were incubated in RPMI1640 medium (Sigma, St. Louis,
MO, USA) containing 5% fetal bovine serum (FBS) under CO2
(5%)-containing humidiﬁed air at 37 C for 24 h in a 35-mm plastic
dish before each experiment. Cell movement on the dish was recorded
using a time-lapse microscope for 90 min after stimulation with 5-HT
and analyzed by an image analyzing software, MetaVue (Universal
Imaging Corporation, PA, USA). Migration velocity of single HAECs
was measured and the mean migration velocity of 20 cells for each
experimental condition was calculated.
2.3. GST pull-down assay for activated RhoA
GST pull-down assay was performed as previously described [9].
Brieﬂy, the cell lysates were incubated with GST-rhotekin Rho-binding
domain (RBD) immobilized on glutathione agarose. The beads were
incubated with the cell lysates, and the proteins on the beads were
run on SDS–PAGE. GTP-bound RhoA was detected by immunoblot-
ting with anti-RhoA polyclonal antibody and anti-GST-Tag antibody.
2.4. Immunostaining
Immunostaining was performed as previously described [10]. Brieﬂy,
the cells stained with Alexa Fluor 488-conjugated phalloidin on the
culture slides were mounted with antifade-containing glycerol/phos-
phate-buﬀered saline, and cell movement was observed under a confo-
cal laser-scanning microscope.
2.5. Western blotting
The cell lysates were separated by SDS–PAGE and transferred to a
polyvinylidene diﬂuoride membrane. The membrane was blocked with
skim milk and then incubated with anti-phospho-p44/p42 or anti-p44/
p42 MAPK polyclonal antibody. The membrane was then incubated
with horseradish peroxidase-conjugated goat anti-rabbit antibodies,
and speciﬁc proteins were detected using an enhanced chemilumines-
cence immunoblotting system.
2.6. Statistical analysis
Statistical analysis was done using analysis of variance followed by
Scheﬀe´s F test. P values less than 0.05 were regarded as signiﬁcant.3. Results and discussion
Fig. 1A shows representative images of HAEC movement.
The cells indicated by the arrows in Fig. 1A started to migrate
following 5-HT stimulation. Ketanserin, a selective 5-HT2
antagonist, did not aﬀect 5-HT-induced migration of HAECs.blished by Elsevier B.V. All rights reserved.
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or 5-HT-stimulated cells in the presence of GR 55562, a selec-
tive 5-HT1 antagonist, and ﬂuoxetine, a 5-HT transporter
inhibitor. Mean migration velocity of HAECs is shown in
Fig. 1B. 5-HT at concentrations from 1 to 100 nM augmented
migration velocity in a concentration-dependent manner. The
augmenting eﬀect of 5-HT (100 nM) on migration of HAECs
was completely inhibited by GR 55562 and ﬂuoxetine but
was not aﬀected by ketanserin. Thus, 5-HT has an enhancing
action on migration of HAECs, which is mediated through
stimulation of 5-HT1 receptors. The present study is the ﬁrst
study that demonstrated 5-HT-induced migration of vascularFig. 1. (A) Time-lapse images of migration of human aortic endothelial cells
(5-HT, 100 nM)-stimulated HAECs and 5-HT (100 nM)-stimulated HAECs
ketanserin (100 nM), a selective 5-HT2 antagonist, or ﬂuoxetine (1 lM), a 5-H
migration velocity of HAECs stimulated with 5-HT (1–100 nM) alone or w
(100 nM) or ﬂuoxetine (1 lM) is shown. Asterisks denote signiﬁcant diﬀerenendothelial cells. High concentrations (almost mM order) of
5-HT have been reported to increase proliferation of canine
and bovine aortic endothelial cells via 5-HT2 receptor stimula-
tion [7,8]. In the present study, 5-HT at lower concentrations
(nM order) increased migration of HAECs through 5HT1
receptor stimulation. Thus, 5-HT is a potent enhancer of vas-
cular endothelial cell migration. On the other hand, 5-HT at
concentrations from 0.1 nM to 1 lM has been reported to in-
hibit migration of bovine aortic endothelial cells through acti-
vation of 5-HT2 receptors, although this 5-HT action did not
show a concentration-dependent manner [6]. These results sug-
gest that the eﬀect of 5-HT on vascular endothelial cell migra-(HAECs). Migration of vehicle-treated HAECs, 5-hydroxytryptamine
in the presence of GR 55562 (100 nM), a selective 5-HT1 antagonist,
T transporter inhibitor, was recorded at the indicated times. (B) Mean
ith 5-HT (100 nM) in the presence of GR 55562 (100 nM), ketanserin
ces (P < 005) from the control without 5-HT stimulation. n = 20.
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mals.
5-HT-associated signal transduction in vascular endothelial
cells has not been clariﬁed in detail. We therefore investigated
the cellular signals involved in 5-HT-induced migration of
HAECs. 5-HT stimulation resulted in a signiﬁcant increase
in RhoA activity at 2.5 min after stimulation with 5-HT
(Fig. 2A). RhoA/Rho kinase signaling is known to play pivotal
roles in endothelial cell movement in response to a variety of
stimuli [11–15]: Activation of Rho increases actin-myosin con-
tractility followed by formation of stress ﬁbers and focal adhe-
sion through Rho-associated kinase (ROCK). Fig. 2B shows
the eﬀects of inhibition of RhoA on 5-HT-induced migration
of HAECs. 5-HT-induced increase in migration velocity of
HAECs was abolished in the presence of Y-27632 and H-
1152, inhibitors of RhoA (Fig. 2B). Similarly, 5-HT-induced
tail retraction and subsequent rear release, which initiated cell
migration, were abolished by Y-27632. (Fig. 2C). Moreover,
we analyzed the integrity of the F-actin cytoskeleton of
HAECs stimulated with 5-HT (Fig. 2D). HAECs stimulated
with 5-HT displayed an array of thick bundled actin stress ﬁ-Fig. 2. (A) 5-Hydroxytryptamine (5-HT)-induced RhoA activation in hum
(100 nM) for the indicated times (min). GTP-bound RhoA was detected b
densitometrical analysis of RhoA activation (lower). The percentage of the va
(B) Eﬀects of RhoA inhibition on migration of HAECs. Mean migration velo
Y-27632 (10 lM) or H-1152 (100 nM) is shown. An asterisk denotes signiﬁ
n = 20. (C) Time-lapse images of HAEC migration. The migration of 5-H
stimulated HAECs in the presence of Y-27632 (10 lM) (lower panel) was re
cytoskeletal structure of HAECs stimulated with 5-HT (100 nM) in the absen
washed, ﬁxed, and processed for visualization of F-actin with Alexa 488-conbers. In contrast, the actin ﬁlaments in HAECs in the presence
of Y27632 were notably less bundled and had an indistinct and
less organized appearance (Fig. 2D). Inhibition of migration is
attributed to the absence of dense actin bundles and failure in
reorganization into actin stress ﬁbers that are essential for cell
migration. Therefore, the RhoA-dependent pathway is in-
volved in 5HT-induced migration of HAECs.
ERK has been reported to be involved in migration of vas-
cular endothelial cells stimulated with EGF-2, angiogenin and
GP 1b [16–18]. Association of the Rho and ERK pathways for
regulation of actin ﬁlaments has also been shown in a variety
of cells, including vascular cells [19–23]. In the present study,
expression of phosphorylated ERK (p44/p42) was increased
from 2.5 min to 15 min after stimulation with 5-HT in a
time-dependent manner (Fig. 3A). 5-HT-induced migration
of HAECs was abolished in the presence of U0126 and
PD98059, inhibitors of ERK (Fig. 3B). 5-HT-induced ERK
activation was abolished in the presence of GR 55562 and ﬂu-
oxetine but not aﬀected in the presence of ketanserin (Fig. 3C).
These results indicate that ERK is activated by stimulation of
5-HT1 receptors and involved in 5-HT-induced migration ofan aortic endothelial cells (HAECs). HAECs were treated with 5-HT
y a pull-down assay using GST-rhotekin RBD (upper). Quantitative
lue at each time relative to the control value at time 0 is shown. n = 3.
city of 5-HT (100 nM)-stimulated HAECs in the presence or absence of
cant diﬀerence (P < 0.05) from the control without 5-HT stimulation.
T (100 nM)-stimulated HAECs (upper panel) and 5-HT (100 nM)-
corded at the indicated times. The arrows indicate uropods. (D) Actin
ce or presence of Y-27632 (10 lM). The cells were grown on coverslips,
jugated phalloidin.
Fig. 3. (A) 5-Hydroxytryptamine (5-HT)-induced ERK (phospho-p44/p42) activation in human aortic endothelial cells (HAECs). HAECs were
treated with 5-HT (100 nM) for the indicated times (min) (upper). Quantitative densitometrical analysis of ERK activation (lower). The percentage of
the value at each time relative to the control value at time 0 is shown. Asterisks denote signiﬁcant diﬀerences (P < 0.05) from the values at time 0.
n = 3. (B) Eﬀects of ERK inhibition on the migration of HAECs. Mean migration velocity of 5-HT (100 nM)-stimulated HAECs in the presence or
absence of U0126 (10 lM) or PD98059 (10 lM) is shown. An asterisk denotes signiﬁcant diﬀerence (P < 0.05) from the control without 5-HT
stimulation. n = 20. (C) Eﬀects of GR 55562 (100 nM), ketanserin (100 nM) or ﬂuoxetine (1 lM) on 5-HT-induced ERK (phospho-p44/p42)
activation in HAECs. HAECs were treated with 5-HT (100 nM) for the indicated times (min). (D) Eﬀects of Y-27632 (10 lM) on 5-HT-induced ERK
(phospho-p44/p42) activation in HAECs. HAECs were treated with 5-HT (100 nM) for the indicated times (min).
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(Fig. 3D), indicating that ERK is a downstream signal of Rho
kinase. Therefore, 5-HT augments migration of HAECs
through the RhoA-ERK pathway. Since therapies designed
to control angiogenesis oﬀer promise for the treatment of
important pathologies, such as tumor growth and metastasis,
modulators of the RhoA-ERK pathway as well as 5-HT1-
receptor antagonists are proposed to be useful tools for inhibi-
tion of angiogenesis by decreasing vascular endothelial cell
migration.
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